Indication
Myoma
8 clinical trials
13 products
Clinical trial
The Efficacy Of Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal MyomectomyStatus: Recruiting, Estimated PCD: 2024-12-01
Product
MisoprostolProduct
OxytocinClinical trial
Randomized Control Trial Investigating for Prophylactic Tranexamic Acid Use at Time of Minimally Invasive MyomectomiesStatus: Recruiting, Estimated PCD: 2024-07-30
Product
Tranexamic AcidProduct
PlacebosClinical trial
The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations: Double Blinded Randomized Placebo-Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-30
Product
TerlipressinClinical trial
The Comparison of the Effectiveness of Rectal Misoprostol and Intravenous Tranexamic Acid in Reducing Intraoperative Bleeding in Patients Undergoing MyomectomyStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Product
CytotecProduct
TransamineClinical trial
A Prospective Randomized Study Comparing Different Types of Local Anesthesia in Outpatient Procedural HysteroscopyStatus: Not yet recruiting, Estimated PCD: 2024-09-01
Product
BupivacaineClinical trial
Comparing the Effectiveness of Misoprostol, Oxytocin, Carbetocin, Vasopressin, Bupivacaine and Epinephrine, Combined IV TXA Acid and Ethamsylate and Peri Cervical Tourniquet for the Reduction of Blood Loss During of Abdominal Myomectomy.Status: Recruiting, Estimated PCD: 2023-10-30
Product
CarbetocinProduct
Combined TXA + EthamsylateProduct
VasopressinProduct
Bupivacaine HydrochlorideClinical trial
Preoperative Vaginal Dinoprostone Versus Misoprostone to Decrease Bleeding During Abdominal MyomectomyStatus: Completed, Estimated PCD: 2023-02-15
Product
DinoprostoneClinical trial
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets: Double Blinded Randomized Placebo-Controlled TrialStatus: Completed, Estimated PCD: 2024-03-29